PMCB
PharmaCyte Biotech Inc
NASDAQ: PMCB · HEALTHCARE · BIOTECHNOLOGY
$0.75
-1.32% today
Updated 2026-04-29
Market cap
$8.05M
P/E ratio
—
P/S ratio
12,904.41x
EPS (TTM)
$-0.89
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
PharmaCyte Biotech Inc (PMCB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-8.24%
ROA
-6.75%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $537038.00 | $-9.38M | 100.00% | -1,365.83% | -1,747.55% |
| 2007 | $1.17M | $-3.61M | 85.35% | -308.29% | -308.89% |
| 2008 | $1.19M | $-3.79M | 77.63% | -315.04% | -318.66% |
| 2009 | $653134.00 | $-6.04M | 34.56% | -945.75% | -925.08% |
| 2010 | $262932.00 | $-5.99M | 13.03% | -802.09% | -2,278.89% |
| 2011 | $125997.00 | $-1.40M | 74.52% | -307.94% | -1,109.55% |
| 2012 | $66558.00 | $-1.90M | 70.88% | -2,928.27% | -2,853.15% |
| 2013 | $12160.00 | $-1.60M | 20.89% | -13,848.68% | -13,141.45% |
| 2014 | $0.00 | $-27.25M | — | — | — |
| 2015 | $0.00 | $-10.86M | — | — | — |
| 2016 | $0.00 | $-6.06M | — | — | — |
| 2017 | $0.00 | $-4.44M | — | — | — |
| 2018 | $0.00 | $-6.83M | — | — | — |
| 2019 | $0.00 | $-4.07M | — | — | — |
| 2020 | $0.00 | $-3.83M | — | — | — |
| 2021 | $0.00 | $-3.55M | — | — | — |
| 2022 | $0.00 | $-4.24M | — | — | — |
| 2023 | $0.00 | $-4.32M | — | — | — |
| 2024 | $0.00 | $333763.00 | — | — | — |
| 2025 | $0.00 | $30.66M | — | — | — |